Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All‐Cause Mortality: Observations From the Framingham Study Over 35 Years
Meredith S. Duncan, Ramachandran S. Vasan, Vanessa Xanthakis
Journal of the American Heart Association (2019) Vol. 8, Iss. 11
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
Michaël Domanski, Xin Tian, Colin O. Wu, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 13, pp. 1507-1516
Open Access | Times Cited: 261
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
Josefin Soppert, Michael Lehrke, Nikolaus Marx, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 4-33
Open Access | Times Cited: 244
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease
Brian A. Ference, Deepak L. Bhatt, Alberico L. Catapano, et al.
JAMA (2019) Vol. 322, Iss. 14, pp. 1381-1381
Open Access | Times Cited: 180
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events
Yiyi Zhang, Mark J. Pletcher, Eric Vittinghoff, et al.
JAMA Cardiology (2021) Vol. 6, Iss. 12, pp. 1406-1406
Open Access | Times Cited: 114
Sex differences in lipids: A life course approach
Kirsten B. Holven, Jeanine E. Roeters van Lennep
Atherosclerosis (2023) Vol. 384, pp. 117270-117270
Open Access | Times Cited: 55
The LDL cumulative exposure hypothesis: evidence and practical applications
Brian A. Ference, Eugene Braunwald, Alberico L. Catapano
Nature Reviews Cardiology (2024) Vol. 21, Iss. 10, pp. 701-716
Closed Access | Times Cited: 20
Cholesterol and Atherosclerotic Cardiovascular Disease: A Lifelong Problem
Samuel S. Gidding, Norrina B. Allen
Journal of the American Heart Association (2019) Vol. 8, Iss. 11
Open Access | Times Cited: 83
Relationship between lipoproteins, thrombosis, and atrial fibrillation
Wern Yew Ding, Majd Protty, Ian G. Davies, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 3, pp. 716-731
Open Access | Times Cited: 70
Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection
James R. Hilser, Yi Han, Subarna Biswas, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100061-100061
Open Access | Times Cited: 66
Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia
Melania Gaggini, Francesca Gorini, Cristina Vassalle
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 75-75
Open Access | Times Cited: 64
Transcriptome analysis reveals sexual disparities in gene expression in rat brain microvessels
Partha K. Chandra, Siniša Čikić, Melody Baddoo, et al.
Journal of Cerebral Blood Flow & Metabolism (2021) Vol. 41, Iss. 9, pp. 2311-2328
Open Access | Times Cited: 59
Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy
Michael Tran Duong, Ilya M. Nasrallah, David A. Wolk, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 56
Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia
Shirin Ibrahim, Laurens F. Reeskamp, Jim N. de Goeij, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 7, pp. 892-900
Open Access | Times Cited: 8
Joint genotypic and phenotypic outcome modeling improves base editing variant effect quantification
Jayoung Ryu, Sam Barkal, Tian Yu, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 925-937
Closed Access | Times Cited: 8
Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration
Christa M. Cobbaert, Harald Althaus, Ilijana Begcevic Brkovic, et al.
Clinical Chemistry (2020) Vol. 67, Iss. 3, pp. 478-489
Open Access | Times Cited: 66
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
Daniel I. Swerdlow, David A. Rider, Arash Yavari, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 5, pp. 1218-1231
Open Access | Times Cited: 46
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
Michael J. Wilkinson, Norman E. Lepor, Erin D. Michos
Journal of the American Heart Association (2023) Vol. 12, Iss. 11
Open Access | Times Cited: 16
A naturally occurring variant of SHLP2 is a protective factor in Parkinson’s disease
Su‐Jeong Kim, Brendan Miller, Nicolas Hartel, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 2, pp. 505-517
Open Access | Times Cited: 6
Pediatric Lipid Screening Prevalence Using Nationwide Electronic Medical Records
Angela M. Thompson‐Paul, Emily M. Kraus, Renee M. Porter, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2421724-e2421724
Open Access | Times Cited: 6
Associations of plasma metal concentrations with incident dyslipidemia: Prospective findings from the Dongfeng-Tongji cohort
Qin Jiang, Yang Xiao, Pinpin Long, et al.
Chemosphere (2021) Vol. 285, pp. 131497-131497
Open Access | Times Cited: 36
The Role of Essential Oils and Their Main Compounds in the Management of Cardiovascular Disease Risk Factors
Jorge M. Alves-Silva, Mónica Zuzarte, Henrique Girão, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3506-3506
Open Access | Times Cited: 34
Biomarkers for Atrial Fibrillation Detection After Stroke
Alan C. Cameron, Huen Ki Cheng, Ren-Ping Lee, et al.
Neurology (2021) Vol. 97, Iss. 18
Closed Access | Times Cited: 32
Lipid levels in midlife and risk of atrial fibrillation over 3 decades—Experience from the Swedish AMORIS cohort: A cohort study
Mozhu Ding, Alexandra Wennberg, Bruna Gigante, et al.
PLoS Medicine (2022) Vol. 19, Iss. 8, pp. e1004044-e1004044
Open Access | Times Cited: 25
Equivalent Carbon Number and Interclass Retention Time Conversion Enhance Lipid Identification in Untargeted Clinical Lipidomics
Jake White, Paul J. Trim, Thalia Salagaras, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 8, pp. 3476-3484
Open Access | Times Cited: 23
Profile of Lipoprotein Subclasses in Chinese Primary Open-Angle Glaucoma Patients
Changzhen Fu, Jianming Xu, Shao-Lang Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4544-4544
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top